Intracranial Therapeutic Delivery Market Size, Trends, Share, Growth, and Regional Forecast, 2025 - 2032

Intracranial Therapeutic Delivery Market by Therapy (Cell-based Therapy, Gene Therapy, Enzyme Replacement Therapy), by Indication (Spinal Muscular Atrophy (SMA), Multiple Sclerosis, Batten Disease, Amyotrophic Lateral Sclerosis), and Regional Analysis from 2025 - 2032

ID: PMRREP33142| 200 Pages | 2 Dec 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Intracranial Therapeutic Delivery Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Therapy Adoption Analysis
    2. Disease Epidemiology
    3. Regulatory Landscape
    4. Value Chain Analysis
    5. Key Deals and Mergers
    6. PESTLE Analysis
    7. Porter’s Five Force Analysis
  4. Global Intracranial Therapeutic Delivery Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
    3. Global Intracranial Therapeutic Delivery Market Outlook: Therapy
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Therapy, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2025 - 2032
        1. Cell-based Therapy
        2. Gene Therapy
        3. Enzyme Replacement Therapy
      4. Market Attractiveness Analysis: Therapy
    4. Global Intracranial Therapeutic Delivery Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
        1. Spinal Muscular Atrophy (SMA)
        2. Multiple Sclerosis
        3. Batten Disease
        4. Amyotrophic Lateral Sclerosis
      4. Market Attractiveness Analysis: Indication
  5. Global Intracranial Therapeutic Delivery Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Intracranial Therapeutic Delivery Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Therapy
      3. By Indication
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2025 - 2032
      1. Cell-based Therapy
      2. Gene Therapy
      3. Enzyme Replacement Therapy
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Spinal Muscular Atrophy (SMA)
      2. Multiple Sclerosis
      3. Batten Disease
      4. Amyotrophic Lateral Sclerosis
    6. Market Attractiveness Analysis
  7. Europe Intracranial Therapeutic Delivery Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Therapy
      3. By Indication
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2025 - 2032
      1. Cell-based Therapy
      2. Gene Therapy
      3. Enzyme Replacement Therapy
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Spinal Muscular Atrophy (SMA)
      2. Multiple Sclerosis
      3. Batten Disease
      4. Amyotrophic Lateral Sclerosis
    6. Market Attractiveness Analysis
  8. East Asia Intracranial Therapeutic Delivery Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Therapy
      3. By Indication
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2025 - 2032
      1. Cell-based Therapy
      2. Gene Therapy
      3. Enzyme Replacement Therapy
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Spinal Muscular Atrophy (SMA)
      2. Multiple Sclerosis
      3. Batten Disease
      4. Amyotrophic Lateral Sclerosis
    6. Market Attractiveness Analysis
  9. South Asia & Oceania Intracranial Therapeutic Delivery Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Therapy
      3. By Indication
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2025 - 2032
      1. Cell-based Therapy
      2. Gene Therapy
      3. Enzyme Replacement Therapy
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Spinal Muscular Atrophy (SMA)
      2. Multiple Sclerosis
      3. Batten Disease
      4. Amyotrophic Lateral Sclerosis
    6. Market Attractiveness Analysis
  10. Latin America Intracranial Therapeutic Delivery Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Therapy
      3. By Indication
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2025 - 2032
      1. Cell-based Therapy
      2. Gene Therapy
      3. Enzyme Replacement Therapy
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Spinal Muscular Atrophy (SMA)
      2. Multiple Sclerosis
      3. Batten Disease
      4. Amyotrophic Lateral Sclerosis
    6. Market Attractiveness Analysis
  11. Middle East & Africa Intracranial Therapeutic Delivery Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Therapy
      3. By Indication
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2025 - 2032
      1. Cell-based Therapy
      2. Gene Therapy
      3. Enzyme Replacement Therapy
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Spinal Muscular Atrophy (SMA)
      2. Multiple Sclerosis
      3. Batten Disease
      4. Amyotrophic Lateral Sclerosis
    6. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Novartis AG
        1. Overview
        2. Segments and Indications
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. BioMarin
      3. CORESTEM Inc.
      4. Alaunos Therapeutics, Inc.
      5. Apic Bio
      6. Stemedica Cell Technologies, Inc.
      7. Voyager Therapeutics
      8. Bayer AG
      9. Abeona Therapeutics
      10. Spark Therapeutics
      11. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate